Variant report
Variant | nsv1060228 |
---|---|
Chromosome Location | chr22:23053532-23255556 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5173)
- CpG islands (count:122)
- Chromatin interactive region (count:443)
- LncRNA region (count:23)
- Mature miRNA region (count: 3)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr22:23096142-23096349 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr22:23062560-23063183 | K562 | blood: | n/a | n/a |
3 | ARID3A | chr22:23226039-23226556 | K562 | blood: | n/a | n/a |
4 | ARID3A | chr22:23123576-23123779 | K562 | blood: | n/a | n/a |
5 | ARID3A | chr22:23112680-23113069 | K562 | blood: | n/a | n/a |
6 | ARID3A | chr22:23088195-23088474 | K562 | blood: | n/a | n/a |
7 | ARID3A | chr22:23122421-23122441 | K562 | blood: | n/a | n/a |
8 | ARID3A | chr22:23232773-23233217 | K562 | blood: | n/a | n/a |
9 | ARID3A | chr22:23062845-23063144 | HepG2 | liver: | n/a | n/a |
10 | ARID3A | chr22:23119431-23119566 | K562 | blood: | n/a | n/a |
11 | ARID3A | chr22:23095901-23096393 | K562 | blood: | n/a | n/a |
12 | ARID3A | chr22:23071123-23071265 | K562 | blood: | n/a | n/a |
13 | ARID3A | chr22:23185588-23185620 | K562 | blood: | n/a | n/a |
14 | ATF1 | chr22:23223851-23224186 | K562 | blood: | n/a | n/a |
15 | ATF1 | chr22:23094264-23095307 | K562 | blood: | n/a | n/a |
16 | ATF1 | chr22:23055701-23055768 | K562 | blood: | n/a | n/a |
17 | ATF1 | chr22:23105060-23105238 | K562 | blood: | n/a | n/a |
18 | ATF1 | chr22:23143924-23144313 | K562 | blood: | n/a | n/a |
19 | ATF1 | chr22:23092911-23093602 | K562 | blood: | n/a | n/a |
20 | ATF1 | chr22:23104460-23104637 | K562 | blood: | n/a | n/a |
21 | ATF1 | chr22:23147092-23147291 | K562 | blood: | n/a | n/a |
22 | ATF1 | chr22:23076119-23076216 | K562 | blood: | n/a | n/a |
23 | ATF1 | chr22:23138336-23138394 | K562 | blood: | n/a | n/a |
24 | ATF1 | chr22:23084998-23085399 | K562 | blood: | n/a | n/a |
25 | ATF1 | chr22:23112583-23113133 | K562 | blood: | n/a | n/a |
26 | ATF1 | chr22:23088109-23088530 | K562 | blood: | n/a | n/a |
27 | ATF1 | chr22:23090785-23091442 | K562 | blood: | n/a | n/a |
28 | ATF1 | chr22:23249632-23250275 | K562 | blood: | n/a | n/a |
29 | ATF1 | chr22:23155091-23155700 | K562 | blood: | n/a | n/a |
30 | ATF1 | chr22:23208195-23208865 | K562 | blood: | n/a | n/a |
31 | ATF1 | chr22:23254917-23254918 | K562 | blood: | n/a | n/a |
32 | ATF1 | chr22:23166948-23167148 | K562 | blood: | n/a | n/a |
33 | ATF1 | chr22:23172635-23172845 | K562 | blood: | n/a | n/a |
34 | ATF1 | chr22:23065741-23065840 | K562 | blood: | n/a | n/a |
35 | ATF1 | chr22:23096027-23096489 | K562 | blood: | n/a | n/a |
36 | ATF1 | chr22:23069790-23071225 | K562 | blood: | n/a | n/a |
37 | ATF1 | chr22:23189882-23189945 | K562 | blood: | n/a | n/a |
38 | ATF1 | chr22:23078516-23079011 | K562 | blood: | n/a | n/a |
39 | ATF1 | chr22:23151564-23151800 | K562 | blood: | n/a | n/a |
40 | ATF1 | chr22:23180385-23181176 | K562 | blood: | n/a | n/a |
41 | ATF1 | chr22:23203233-23203487 | K562 | blood: | n/a | n/a |
42 | ATF1 | chr22:23125944-23126543 | K562 | blood: | n/a | n/a |
43 | ATF1 | chr22:23111363-23111688 | K562 | blood: | n/a | n/a |
44 | ATF1 | chr22:23110486-23110686 | K562 | blood: | n/a | n/a |
45 | ATF1 | chr22:23086152-23086162 | K562 | blood: | n/a | n/a |
46 | ATF1 | chr22:23158393-23159026 | K562 | blood: | n/a | n/a |
47 | ATF1 | chr22:23203811-23204540 | K562 | blood: | n/a | n/a |
48 | ATF1 | chr22:23066966-23067564 | K562 | blood: | n/a | n/a |
49 | ATF1 | chr22:23205123-23205389 | K562 | blood: | n/a | n/a |
50 | ATF1 | chr22:23072639-23072759 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:23196971-23197021 | SAEC | small airway: | n/a |
2 | chr22:23196862-23196912 | BE2_C | brain: | n/a |
3 | chr22:23196862-23196912 | BJ | skin: | n/a |
4 | chr22:23196862-23196912 | HCM | heart: | n/a |
5 | chr22:23196862-23196912 | HCPEpiC | choroid plexus: | n/a |
6 | chr22:23196971-23197021 | HIPEpiC | eye: | n/a |
7 | chr22:23196862-23196912 | HNPCEpiC | eye: | n/a |
8 | chr22:23196862-23196912 | SK-N-SH_RA | brain: | n/a |
9 | chr22:23196862-23196912 | Jurkat | blood: | n/a |
10 | chr22:23196971-23197021 | PrEC | prostate: | n/a |
11 | chr22:23196971-23197021 | H1-hESC | embryonic stem cell: | embryo |
12 | chr22:23196971-23197021 | ProgFib | skin: | n/a |
13 | chr22:23196971-23197021 | SK-N-SH_RA | brain: | n/a |
14 | chr22:23196862-23196912 | ECC-1 | luminal epithelium: | n/a |
15 | chr22:23196862-23196912 | LNCaP | prostate: | n/a |
16 | chr22:23196862-23196912 | HAEpiC | amniotic membrane: | n/a |
17 | chr22:23196862-23196912 | ovcar-3 | ovarian: | n/a |
18 | chr22:23196862-23196912 | NT2-D1 | testis: | n/a |
19 | chr22:23196971-23197021 | AG09309 | skin: | n/a |
20 | chr22:23196971-23197021 | AG04449 | skin: | fetal |
21 | chr22:23196862-23196912 | AG09309 | skin: | n/a |
22 | chr22:23196862-23196912 | NHDF-neo | bronchial: | n/a |
23 | chr22:23196971-23197021 | HepG2 | liver: | n/a |
24 | chr22:23196862-23196912 | NH-A | brain: | n/a |
25 | chr22:23196971-23197021 | PFSK-1 | brain: | n/a |
26 | chr22:23196971-23197021 | A549 | lung: | n/a |
27 | chr22:23196862-23196912 | GM12878 | blood: | n/a |
28 | chr22:23196971-23197021 | NB4 | blood: | n/a |
29 | chr22:23196862-23196912 | GM19239 | blood: | n/a |
30 | chr22:23196971-23197021 | AG04450 | lung: | fetal |
31 | chr22:23196971-23197021 | NHBE | bronchial: | n/a |
32 | chr22:23196971-23197021 | SK-N-SH | brain: | n/a |
33 | chr22:23196862-23196912 | GM12892 | blood: | n/a |
34 | chr22:23196862-23196912 | CMK | blood: | n/a |
35 | chr22:23196971-23197021 | LNCaP | prostate: | n/a |
36 | chr22:23196971-23197021 | Caco-2 | colon: | n/a |
37 | chr22:23196862-23196912 | HL-60 | blood: | n/a |
38 | chr22:23196862-23196912 | AG10803 | skin: | n/a |
39 | chr22:23196862-23196912 | HPAEpiC | pulmonary alveolar: | n/a |
40 | chr22:23196862-23196912 | SK-N-MC | brain: | n/a |
41 | chr22:23196971-23197021 | U87 | brain: | n/a |
42 | chr22:23196971-23197021 | RPTEC | kidney: | n/a |
43 | chr22:23196971-23197021 | ECC-1 | luminal epithelium: | n/a |
44 | chr22:23196862-23196912 | Caco-2 | colon: | n/a |
45 | chr22:23196971-23197021 | NH-A | brain: | n/a |
46 | chr22:23196971-23197021 | T-47D | breast: | n/a |
47 | chr22:23196862-23196912 | PANC-1 | pancreas: | n/a |
48 | chr22:23196971-23197021 | AoSMC | blood vessel: | n/a |
49 | chr22:23196971-23197021 | ovcar-3 | ovarian: | n/a |
50 | chr22:23196971-23197021 | AG10803 | skin: | n/a |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:23224116..23226301-chr22:23252932..23255620,2 | K562 | blood: | |
2 | chr22:23190306..23191721-chr22:23225246..23226597,7 | MCF-7 | breast: | |
3 | chr22:23044807..23045428-chr22:23062295..23063052,3 | MCF-7 | breast: | |
4 | chr22:23130059..23131366-chr22:23152103..23153385,6 | K562 | blood: | |
5 | chr22:23044550..23045444-chr22:23053127..23053727,2 | K562 | blood: | |
6 | chr22:22818275..22818824-chr22:23226158..23226792,2 | MCF-7 | breast: | |
7 | chr22:23034942..23035446-chr22:23090868..23091472,2 | K562 | blood: | |
8 | chr22:23152221..23152901-chr22:23190288..23191157,3 | K562 | blood: | |
9 | chr22:23095736..23096392-chr22:23219351..23220241,3 | MCF-7 | breast: | |
10 | chr22:23112331..23113021-chr22:23223423..23224541,3 | K562 | blood: | |
11 | chr22:23151728..23153719-chr22:23225682..23227093,23 | K562 | blood: | |
12 | chr22:23071304..23074253-chr22:23078346..23081293,2 | K562 | blood: | |
13 | chr22:23211841..23214589-chr22:23214813..23217953,3 | K562 | blood: | |
14 | chr22:22818098..22818959-chr22:23130713..23131308,3 | K562 | blood: | |
15 | chr22:22899832..22902524-chr22:23054881..23057157,2 | K562 | blood: | |
16 | chr22:23237287..23240210-chr22:23254703..23257164,2 | K562 | blood: | |
17 | chr22:23198020..23198527-chr22:23209390..23209956,2 | K562 | blood: | |
18 | chr22:23082377..23083071-chr22:23239318..23240169,2 | K562 | blood: | |
19 | chr22:23131123..23132637-chr22:23301462..23303842,2 | K562 | blood: | |
20 | chr22:23049724..23050322-chr22:23112347..23112891,3 | K562 | blood: | |
21 | chr22:23111937..23114253-chr22:23218482..23221359,2 | K562 | blood: | |
22 | chr22:23143333..23145097-chr22:23222921..23225680,2 | K562 | blood: | |
23 | chr22:23198000..23198685-chr22:23284805..23285520,2 | MCF-7 | breast: | |
24 | chr22:23143333..23145097-chr22:23222921..23225680,2 | K562 | blood: | |
25 | chr22:22815066..22815979-chr22:23225208..23226122,2 | K562 | blood: | |
26 | chr22:23221725..23222375-chr22:23284654..23285494,2 | K562 | blood: | |
27 | chr22:23168657..23170784-chr22:23171805..23174406,4 | K562 | blood: | |
28 | chr22:23249849..23250456-chr22:23284637..23285518,2 | K562 | blood: | |
29 | chr22:23112086..23113814-chr22:23188708..23190847,2 | K562 | blood: | |
30 | chr22:23125660..23127842-chr22:23129980..23132039,4 | K562 | blood: | |
31 | chr22:22929292..22930184-chr22:23219224..23220044,2 | K562 | blood: | |
32 | chr22:23149559..23151668-chr22:23154879..23157298,2 | MCF-7 | breast: | |
33 | chr22:23034964..23035875-chr22:23226239..23227006,2 | K562 | blood: | |
34 | chr22:23095720..23096793-chr22:23225681..23226777,7 | K562 | blood: | |
35 | chr22:23197941..23198519-chr22:23296672..23297562,5 | MCF-7 | breast: | |
36 | chr22:23144565..23145628-chr22:23297770..23298814,8 | K562 | blood: | |
37 | chr22:23082377..23083071-chr22:23239318..23240169,2 | K562 | blood: | |
38 | chr22:23204517..23207085-chr22:23207637..23209482,2 | K562 | blood: | |
39 | chr22:23185728..23186473-chr22:23296561..23297083,2 | K562 | blood: | |
40 | chr22:23049285..23050242-chr22:23107821..23108351,2 | K562 | blood: | |
41 | chr22:23061644..23064154-chr22:23089157..23090984,2 | K562 | blood: | |
42 | chr22:23237287..23240210-chr22:23254703..23257164,2 | K562 | blood: | |
43 | chr22:23062316..23063283-chr22:23225816..23226768,5 | K562 | blood: | |
44 | chr22:23152545..23153119-chr22:23292977..23293913,2 | K562 | blood: | |
45 | chr22:23125400..23127839-chr22:23232318..23234700,2 | K562 | blood: | |
46 | chr22:23034627..23035920-chr22:23062552..23063228,3 | K562 | blood: | |
47 | chr22:23145087..23146964-chr22:23157198..23158794,2 | K562 | blood: | |
48 | chr22:23142654..23146460-chr22:23147411..23151043,4 | K562 | blood: | |
49 | chr22:23195204..23197105-chr22:23594404..23596670,2 | K562 | blood: | |
50 | chr22:23219790..23220746-chr22:23282871..23283800,2 | K562 | blood: |
(count:23 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RTDR1-6 | chr22:23221233-23221684 | NONHSAT083832 |
2 | lnc-IGLL5-4 | chr22:23192550-23192799 | NONHSAT083828 |
3 | lnc-POM121L1P-5 | chr22:23220658-23220783 | refGeneNc_260_NR_028483 |
4 | lnc-RTDR1-6 | chr22:23220011-23220059 | NONHSAT083832 |
5 | lnc-GGTLC2-9 | chr22:23098043-23098286 | NONHSAT083817 |
6 | lnc-RTDR1-4 | chr22:23243491-23243570 | NONHSAT083834 |
7 | lnc-D87017.1-3 | chr22:23252998-23253245 | NONHSAT083835 |
8 | lnc-POM121L1P-5 | chr22:23178179-23178296 | refGeneNc_260_NR_028483 |
9 | lnc-RTDR1-1 | chr22:23248506-23248831 | NONHSAT083775 |
10 | lnc-POM121L1P-5 | chr22:23167960-23168108 | refGeneNc_260_NR_028483 |
11 | lnc-RTDR1-4 | chr22:23242926-23243073 | NONHSAT083834 |
12 | lnc-POM121L1P-5 | chr22:23197736-23197863 | refGeneNc_260_NR_028483 |
13 | lnc-POM121L1P-5 | chr22:23186421-23186739 | refGeneNc_260_NR_028483 |
14 | lnc-POM121L1P-4 | chr22:23155178-23156344 | ucscGeneNc_uc002zzz_1 |
15 | lnc-IGLL5-5 | chr22:23180779-23181049 | NONHSAT083827 |
16 | lnc-IGLL5-7 | chr22:23157168-23157423 | NONHSAT083824 |
17 | lnc-GGTLC2-10 | chr22:23104787-23105009 | NONHSAT083819 |
18 | lnc-GGTLC2-8 | chr22:23081432-23081675 | NONHSAT083816 |
19 | lnc-POM121L1P-3 | chr22:23053951-23054068 | NONHSAT083813 |
20 | lnc-POM121L1P-5 | chr22:23200951-23201121 | refGeneNc_260_NR_028483 |
21 | lnc-POM121L1P-5 | chr22:23164245-23164726 | refGeneNc_260_NR_028483 |
22 | lnc-RTDR1-4 | chr22:23243305-23243327 | NONHSAT083834 |
23 | lnc-POM121L1P-5 | chr22:23165262-23165535 | refGeneNc_260_NR_028483 |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-5571-5p | chr22:23228471-23228491 | MIMAT0022257 |
hsa-miR-5571-3p | chr22:23228511-23228529 | MIMAT0022258 |
hsa-miR-650 | chr22:23165285-23165305 | MIMAT0003320 |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000264824 | TF binding region |
IGLV3-7 | TF binding region |
ENSG00000207832 | TF binding region |
IGLV4-3 | TF binding region |
IGLJ5 | TF binding region |
IGLV3-13 | TF binding region |
IGLC1 | TF binding region |
IGLV2-5 | TF binding region |
IGLV2-18 | TF binding region |
IGLV3-17 | TF binding region |
IGLJ6 | TF binding region |
IGLV3-12 | TF binding region |
ENSG00000207835 | TF binding region |
IGLJ2 | TF binding region |
IGLV3-15 | TF binding region |
IGLV3-19 | TF binding region |
IGLV2-14 | TF binding region |
IGLVI-20 | TF binding region |
IGLJ1 | TF binding region |
ENSG00000207833 | TF binding region |
MIR650 | TF binding region |
ENSG00000226477 | TF binding region |
IGLV3-2 | TF binding region |
IGLV3-4 | TF binding region |
ENSG00000237127 | TF binding region |
IGLV3-6 | TF binding region |
IGLV3-16 | TF binding region |
ENSG00000264629 | TF binding region |
IGLJ4 | TF binding region |
IGLC4 | TF binding region |
ENSG00000231392 | TF binding region |
IGLV2-8 | TF binding region |
IGLC5 | TF binding region |
IGLV3-10 | TF binding region |
IGLV2-11 | TF binding region |
IGLL5 | TF binding region |
IGLJ3 | TF binding region |
IGLC3 | TF binding region |
IGLV3-9 | TF binding region |
IGLV3-1 | TF binding region |
IGLV3-21 | TF binding region |
IGLC2 | TF binding region |
ENSG00000264824 | CpG island |
IGLV3-7 | CpG island |
ENSG00000207832 | CpG island |
IGLV4-3 | CpG island |
IGLJ5 | CpG island |
IGLV3-13 | CpG island |
IGLC1 | CpG island |
IGLV2-5 | CpG island |
IGLV2-18 | CpG island |
IGLV3-17 | CpG island |
IGLJ6 | CpG island |
IGLV3-12 | CpG island |
ENSG00000207835 | CpG island |
IGLJ2 | CpG island |
IGLV3-15 | CpG island |
IGLV3-19 | CpG island |
IGLV2-14 | CpG island |
IGLVI-20 | CpG island |
IGLJ1 | CpG island |
ENSG00000207833 | CpG island |
MIR650 | CpG island |
ENSG00000226477 | CpG island |
IGLV3-2 | CpG island |
IGLV3-4 | CpG island |
ENSG00000237127 | CpG island |
IGLV3-6 | CpG island |
IGLV3-16 | CpG island |
ENSG00000264629 | CpG island |
IGLJ4 | CpG island |
IGLC4 | CpG island |
ENSG00000231392 | CpG island |
IGLV2-8 | CpG island |
IGLC5 | CpG island |
IGLV3-10 | CpG island |
IGLV2-11 | CpG island |
IGLL5 | CpG island |
IGLJ3 | CpG island |
IGLC3 | CpG island |
IGLV3-9 | CpG island |
IGLV3-1 | CpG island |
IGLV3-21 | CpG island |
IGLC2 | CpG island |
ENSG00000211672 | chromatin interactions |
ENSG00000264824 | chromatin interactions |
ENSG00000211669 | chromatin interactions |
ENSG00000187556 | chromatin interactions |
ENSG00000211674 | chromatin interactions |
ENSG00000211673 | chromatin interactions |
ENSG00000254030 | chromatin interactions |
ENSG00000211678 | chromatin interactions |
ENSG00000253786 | chromatin interactions |
ENSG00000186716 | chromatin interactions |
ENSG00000226420 | chromatin interactions |
ENSG00000253822 | chromatin interactions |
ENSG00000207832 | chromatin interactions |
ENSG00000253963 | chromatin interactions |
ENSG00000211679 | chromatin interactions |
ENSG00000226477 | chromatin interactions |
ENSG00000211657 | chromatin interactions |
ENSG00000211666 | chromatin interactions |
ENSG00000253234 | chromatin interactions |
ENSG00000185686 | chromatin interactions |
ENSG00000254240 | chromatin interactions |
ENSG00000211682 | chromatin interactions |
ENSG00000264629 | chromatin interactions |
ENSG00000254709 | chromatin interactions |
ENSG00000211681 | chromatin interactions |
ENSG00000231392 | chromatin interactions |
ENSG00000211662 | chromatin interactions |
ENSG00000254077 | chromatin interactions |
ENSG00000237127 | chromatin interactions |
ENSG00000211675 | chromatin interactions |
ENSG00000236794 | chromatin interactions |
ENSG00000211680 | chromatin interactions |
ENSG00000211676 | chromatin interactions |
ENSG00000211665 | chromatin interactions |
ENSG00000220891 | chromatin interactions |
ENSG00000222037 | chromatin interactions |
ENSG00000207835 | chromatin interactions |
ENSG00000207836 | chromatin interactions |
ENSG00000211667 | chromatin interactions |
ENSG00000211663 | chromatin interactions |
ENSG00000254029 | chromatin interactions |
ENSG00000211685 | chromatin interactions |
ENSG00000211684 | chromatin interactions |
ENSG00000211670 | chromatin interactions |
ENSG00000253152 | chromatin interactions |
ENSG00000253448 | chromatin interactions |
ENSG00000253590 | chromatin interactions |
ENSG00000211671 | chromatin interactions |
ENSG00000211664 | chromatin interactions |
ENSG00000211655 | chromatin interactions |
ENSG00000211677 | chromatin interactions |
ENSG00000223999 | chromatin interactions |
ING4 | Mature miRNA region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190467739 | chr22:23053562-23053563 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
2 | rs192981864 | chr22:23053623-23053624 | Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
3 | rs576264286 | chr22:23053708-23053709 | Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
4 | rs78417449 | chr22:23053711-23053712 | Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
5 | rs540459839 | chr22:23053726-23053727 | Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
6 | rs150017497 | chr22:23053747-23053748 | Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
7 | rs116796430 | chr22:23053779-23053780 | Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
8 | rs75494762 | chr22:23053789-23053790 | Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
9 | rs564560383 | chr22:23053790-23053791 | Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
10 | rs144547775 | chr22:23053803-23053804 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
11 | rs543926928 | chr22:23053807-23053808 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
12 | rs184318953 | chr22:23053826-23053827 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
13 | rs77613054 | chr22:23053827-23053828 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
14 | rs549262725 | chr22:23053877-23053878 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs148466822 | chr22:23053902-23053903 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs116117878 | chr22:23053920-23053921 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs114836025 | chr22:23053924-23053925 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs571260869 | chr22:23053940-23053941 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs536732342 | chr22:23054042-23054043 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive regionlncRNA | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs550290510 | chr22:23054058-23054059 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive regionlncRNA | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs145246136 | chr22:23054070-23054071 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs16991444 | chr22:23054081-23054082 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs188656683 | chr22:23054089-23054090 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs555602410 | chr22:23054114-23054115 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs16991445 | chr22:23054127-23054128 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs142297030 | chr22:23054159-23054160 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs75964429 | chr22:23054181-23054182 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs181143105 | chr22:23054185-23054186 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs75797398 | chr22:23054197-23054198 | Enhancers Weak transcription Flanking Active TSS Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs149400230 | chr22:23054207-23054208 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs368629955 | chr22:23054208-23054209 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs115752598 | chr22:23054227-23054228 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs144167946 | chr22:23054250-23054251 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs6003234 | chr22:23054251-23054252 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs140171573 | chr22:23054252-23054253 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs80230004 | chr22:23054273-23054274 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs111761358 | chr22:23054276-23054277 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs118059459 | chr22:23054277-23054278 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs530550748 | chr22:23054278-23054279 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs74765210 | chr22:23054324-23054325 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs150335839 | chr22:23054336-23054337 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs138266521 | chr22:23054344-23054345 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs549165023 | chr22:23054367-23054368 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs6003235 | chr22:23054375-23054376 | Enhancers Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs553717139 | chr22:23054395-23054396 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs6003236 | chr22:23054411-23054412 | Enhancers Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs558444846 | chr22:23054432-23054433 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34972066 | chr22:23054436-23054437 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571515479 | chr22:23054440-23054441 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs5996353 | chr22:23054454-23054455 | Enhancers Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Disease | 21346257 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Asthma | 21956041 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
22q11.23 microdeletion syndrome | 19193630 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 20841430 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Ependymoma | 20639864 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 17989066 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:23050800-23054800 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
2 | chr22:23051600-23056800 | Strong transcription | Right Atrium | heart |
3 | chr22:23052400-23054600 | Enhancers | Stomach Mucosa | stomach |
4 | chr22:23052600-23053800 | Enhancers | Duodenum Mucosa | Duodenum |
5 | chr22:23052600-23059600 | Enhancers | Primary B cells from cord blood | blood |
6 | chr22:23053000-23053600 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr22:23053000-23053600 | Weak transcription | Spleen | Spleen |
8 | chr22:23053000-23053800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr22:23053000-23058800 | Enhancers | Primary B cells from peripheral blood | blood |
10 | chr22:23053200-23054800 | Enhancers | Ovary | ovary |
11 | chr22:23053400-23053800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
12 | chr22:23053400-23054200 | Enhancers | Pancreas | Pancrea |
13 | chr22:23053400-23054600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
14 | chr22:23053600-23053800 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
15 | chr22:23053600-23053800 | Bivalent Enhancer | Stomach Smooth Muscle | stomach |
16 | chr22:23053600-23053800 | Enhancers | Spleen | Spleen |
17 | chr22:23053600-23054200 | Enhancers | Adipose Nuclei | Adipose |
18 | chr22:23053600-23055400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr22:23053800-23054000 | Enhancers | Muscle Satellite Cultured Cells | -- |
20 | chr22:23053800-23054600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
21 | chr22:23053800-23055000 | Weak transcription | Spleen | Spleen |
22 | chr22:23053800-23055400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
23 | chr22:23053800-23062600 | Weak transcription | Duodenum Mucosa | Duodenum |
24 | chr22:23054000-23054200 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
25 | chr22:23054200-23054600 | Enhancers | Primary hematopoietic stem cells | blood |
26 | chr22:23054200-23054600 | Enhancers | Muscle Satellite Cultured Cells | -- |
27 | chr22:23054200-23058400 | Enhancers | GM12878-XiMat | blood |
28 | chr22:23054600-23054800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
29 | chr22:23054600-23055000 | Weak transcription | Primary hematopoietic stem cells | blood |
30 | chr22:23054600-23055200 | Enhancers | Colonic Mucosa | Colon |
31 | chr22:23054600-23056600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
32 | chr22:23054800-23055000 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
33 | chr22:23054800-23055200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
34 | chr22:23054800-23056800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
35 | chr22:23055000-23055200 | Enhancers | Primary hematopoietic stem cells | blood |
36 | chr22:23055000-23056200 | Enhancers | Spleen | Spleen |
37 | chr22:23055200-23059800 | Weak transcription | Primary hematopoietic stem cells | blood |
38 | chr22:23055200-23060000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
39 | chr22:23055400-23055800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
40 | chr22:23055400-23057800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
41 | chr22:23055400-23059000 | Enhancers | Primary monocytes fromperipheralblood | blood |
42 | chr22:23055400-23059600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
43 | chr22:23055800-23056000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
44 | chr22:23056000-23059800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
45 | chr22:23056200-23063200 | Weak transcription | Spleen | Spleen |
46 | chr22:23056600-23057600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
47 | chr22:23056800-23070000 | Weak transcription | Right Atrium | heart |
48 | chr22:23057600-23058600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
49 | chr22:23057800-23058000 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
50 | chr22:23058000-23058200 | Enhancers | Monocytes-CD14+_RO01746 | blood |